Abstract: A method of estimating gestational age (GA) is shown generally at 3000. At Step 3010 an ultrasound image is acquired. The image is fed into the model at Step 3020 and a predicted GA value, together with an associated confidence interval are calculated at Step 3030. At Step 3040 it is determined whether the confidence interval is narrower than a value for the best confidence interval obtained. If not, the ultrasound operation is optionally directed to acquire an ultrasound image of a particular plane in the fetus at Step 3050. On the other hand, if the value is determined to be narrower than the best obtained at Step 3040, the predicted value and confidence interval are displayed at Step 3060 and a register for the value of the best confidence interval is updated at Step 3070.

Abstract: In a method of modelling data, using a neural network, the neural network is trained using data comprising a plurality of input variables and a plurality of output variables, wherein the method comprises constraining the neural network so that a monotonic relationship exists between one or more selected input variables and one or more related output variables.

Abstract: Provided are sunflowers, parts thereof, cultures of, and seeds that are capable of producing sunflower oil that is low in saturated fat as well as associated methods.

Abstract: Provided are sunflowers, parts thereof, cultures of, and seeds that are capable of producing sunflower oil that is low in saturated fat as well as associated methods.

Abstract: The present invention relates to an inbred sunflower line, designated OIN807A/B. The invention relates to the seeds of inbred sunflower line OIN807A/B, to the plants of inbred sunflower line OIN807A/B and to the methods for producing a sunflower plant, either inbred or hybrid, by crossing the inbred line OIN807A/B with itself or another sunflower line. The invention further relates to methods for producing a sunflower plant containing in its genetic material one or more transgenes and to the transgenic plants produced by that method and to methods for producing other inbred sunflower lines derived from the inbred OIN807A/B.

Abstract: The present invention relates to compounds of formula (I), as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein A, B, R1, R2, R3, R4, R5, n, m and p have the significance defined herein.

Abstract: This invention relates to novel cyclopentyl- and cycloheptylpyrazole derivatives of the formula I wherein A and R1 to R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. The invention relates also to compositions including these compounds and methods of using the compounds.

Abstract: This invention relates to novel indazole derivatives of formula I: wherein R1 to R7 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are FXR modulators and can be used as medicaments.

Abstract: The invention is concerned with novel benzimidazole derivatives of formula (I) wherein R1 to R6 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds can be used as medicaments.

Abstract: The invention is concerned with novel benzimidazole derivatives of formula (I) wherein A, n and R1 to R7 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds can be used as medicaments.

Abstract: This invention relates to novel cyclopentyl- and cycloheptylpyrazole derivatives of the formula I wherein A and R1 to R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. The invention relates also to compositions including these compounds and methods of using the compounds.

Abstract: The invention is concerned with novel substituted benzimidazole derivatives of formula (I) wherein R1 to R10 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds can be used as medicaments.

Abstract: This invention relates to novel indazole or 4,5,6,7-tetrahydro-indazole derivatives of formula I wherein R1 to R8 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are FXR modulators and can be used as medicaments.

Abstract: An inbred sunflower line, designated CN1703, the plants and seeds of the inbred sunflower line CN1703, methods for producing a sunflower plant, either inbred or hybrid, produced by crossing the inbred sunflower line CN1703 with itself or with another sunflower plant, and hybrid sunflower seeds and plants produced by crossing the inbred line CN1703 with another sunflower line or plant and to methods for producing a sunflower plant containing in its genetic material one or more transgenes and to the transgenic sunflower plants produced by that method. This invention also relates to inbred sunflower lines derived from inbred sunflower line CN1703, to methods for producing other inbred sunflower lines derived from inbred sunflower line CN1703 and to the inbred sunflower lines derived by the use of those methods.

Abstract: The present invention relates to compounds of formula (I), as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein A, B, R1, R2, R3, R4, R5, n, m and p have the significance defined herein.

Abstract: The invention is concerned with novel substituted benzimidazole derivatives of formula (I) wherein R1 to R10 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds can be used as medicaments.

Abstract: The invention is concerned with novel substituted benzimidazole derivatives of formula (I) wherein R1 to R10 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds can be used as medicaments.

Abstract: This invention relates to novel carboxyl- or hydroxyl-substituted benzimidazole derivatives of formula (I) wherein R1 to R6 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to FXR and can be used as medicaments.

Abstract: The invention is concerned with novel substituted benzimidazole derivatives of formula (I) wherein R1 to R10 and X are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to FXR and can be used as medicaments.